Literature DB >> 19418579

Tropheryma whipplei infection.

Hugh James Freeman1.   

Abstract

Whipple's disease was initially described in 1907. Over the next century, the clinical and pathological features of this disorder have been better appreciated. Most often, weight loss, diarrhea, abdominal and joint pain occur. Occasionally, other sites of involvement have been documented, including isolated neurological disease, changes in the eyes and culture-negative endocarditis. In the past decade, the responsible organism Tropheryma whipplei has been cultivated, its genome sequenced and its antibiotic susceptibility defined. Although rare, it is a systemic infection that may mimic a wide spectrum of clinical disorders and may have a fatal outcome. If recognized, prolonged antibiotic therapy may be a very successful form of treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19418579      PMCID: PMC2678577          DOI: 10.3748/wjg.15.2078

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

Review 1.  Neurologic presentation of Whipple disease: report of 12 cases and review of the literature.

Authors:  Antoine Gerard; Françoise Sarrot-Reynauld; Eric Liozon; Pascal Cathebras; Gerard Besson; Christophe Robin; Alain Vighetto; Jean-François Mosnier; Isabelle Durieu; Denis Vital Durand; Hugues Rousset
Journal:  Medicine (Baltimore)       Date:  2002-11       Impact factor: 1.889

2.  Mosaic-patterned and scalloped duodenal mucosa in Whipple's disease.

Authors:  Franco Armelao; Federica Portolan; Roberto Togni
Journal:  Clin Gastroenterol Hepatol       Date:  2008-08-08       Impact factor: 11.382

3.  Antibiotic treatment and relapse in Whipple's disease. Long-term follow-up of 88 patients.

Authors:  R D Keinath; D E Merrell; R Vlietstra; W O Dobbins
Journal:  Gastroenterology       Date:  1985-06       Impact factor: 22.682

4.  Manifestations of Whipple's disease in the posterior segment of the eye.

Authors:  M P Avila; A E Jalkh; E Feldman; C L Trempe; C L Schepens
Journal:  Arch Ophthalmol       Date:  1984-03

5.  Diagnosis of Wihipple disease by immunohistochemical analysis: a sensitive and specific method for the detection of Tropheryma whipplei (the Whipple bacillus) in paraffin-embedded tissue.

Authors:  Blaire L Baisden; Hubert Lepidi; Didier Raoult; Pedram Argani; John H Yardley; J Stephen Dumler
Journal:  Am J Clin Pathol       Date:  2002-11       Impact factor: 2.493

6.  Cultivation of the bacillus of Whipple's disease.

Authors:  D Raoult; M L Birg; B La Scola; P E Fournier; M Enea; H Lepidi; V Roux; J C Piette; F Vandenesch; D Vital-Durand; T J Marrie
Journal:  N Engl J Med       Date:  2000-03-02       Impact factor: 91.245

7.  Sequencing and analysis of the genome of the Whipple's disease bacterium Tropheryma whipplei.

Authors:  Stephen D Bentley; Matthias Maiwald; Lee D Murphy; Mark J Pallen; Corin A Yeats; Lynn G Dover; Halina T Norbertczak; Gurdyal S Besra; Michael A Quail; David E Harris; Axel von Herbay; Arlette Goble; Simon Rutter; Robert Squares; Stephen Squares; Bart G Barrell; Julian Parkhill; David A Relman
Journal:  Lancet       Date:  2003-02-22       Impact factor: 79.321

8.  Cardiac valves in patients with Whipple endocarditis: microbiological, molecular, quantitative histologic, and immunohistochemical studies of 5 patients.

Authors:  Hubert Lepidi; Florence Fenollar; J Stephen Dumler; Valérie Gauduchon; Lara Chalabreysse; Antoine Bammert; Marie-France Bonzi; Françoise Thivolet-Béjui; François Vandenesch; Didier Raoult
Journal:  J Infect Dis       Date:  2004-07-27       Impact factor: 5.226

9.  Tropheryma whipplei Twist: a human pathogenic Actinobacteria with a reduced genome.

Authors:  Didier Raoult; Hiroyuki Ogata; Stephane Audic; Catherine Robert; Karsten Suhre; Michel Drancourt; Jean-Michel Claverie
Journal:  Genome Res       Date:  2003-08       Impact factor: 9.043

10.  Antibiotic susceptibility of Tropheryma whipplei in MRC5 cells.

Authors:  Areen Boulos; Jean-Marc Rolain; Didier Raoult
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

View more
  7 in total

1.  Intestinal lymphangiectasia in adults.

Authors:  Hugh James Freeman; Michael Nimmo
Journal:  World J Gastrointest Oncol       Date:  2011-02-15

2.  Design of a Multi-Epitope Vaccine against Tropheryma whipplei Using Immunoinformatics and Molecular Dynamics Simulation Techniques.

Authors:  Thamer H Albekairi; Abdulrahman Alshammari; Metab Alharbi; Amal F Alshammary; Muhammad Tahir Ul Qamar; Tasneem Anwar; Saba Ismail; Bilal Shaker; Sajjad Ahmad
Journal:  Vaccines (Basel)       Date:  2022-04-28

Review 3.  Whipple's disease infection surgical treatment: presentation of a rare case and literature review.

Authors:  M Amendolara; C Barbarino; D Bucca; G Stevanato; M Zucchelli; F Romano; L Baiano; M Bernardi; A Broggiato; S Ramuscello; M Rizzo
Journal:  G Chir       Date:  2013-04

4.  Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease.

Authors:  Raphael B Stricker; Allison K Delong; Christine L Green; Virginia R Savely; Stanley N Chamallas; Lorraine Johnson
Journal:  Int J Gen Med       Date:  2011-09-06

5.  Refractory Effusions, Crumbly Bones, Mystifying Cachexia and an Absent Mind: An Unusual Presentation of Whipple's Disease with Review of Literature.

Authors:  Syed Hamza Bin Waqar; John Diks; Unaiza Zaman; Sarah Sharif; Taha Sheikh; Srinivas Kolla; Isabel M McFarlane
Journal:  Am J Med Case Rep       Date:  2021-04-01

6.  Whipple's Disease: Our Own Experience and Review of the Literature.

Authors:  Jan Bureš; Marcela Kopáčová; Tomáš Douda; Jolana Bártová; Jan Tomš; Stanislav Rejchrt; Ilja Tachecí
Journal:  Gastroenterol Res Pract       Date:  2013-06-17       Impact factor: 2.260

7.  Arthralgia and blood culture-negative endocarditis in middle Age Men suggest tropheryma whipplei infection: report of two cases and review of the literature.

Authors:  Anthony Alozie; Annette Zimpfer; Kerstin Köller; Bernd Westphal; Annette Obliers; Andreas Erbersdobler; Gustav Steinhoff; Andreas Podbielski
Journal:  BMC Infect Dis       Date:  2015-08-18       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.